Joint letter to FDA re: Temporary flexibility in certain food labeling
Sign-on letter requests online allergen notification
The FDA has released guidance relaxing certain food labeling requirements for industry in the context of the pandemic. We recommend that the FDA require a manufacturer that makes any substitution to simply put a statement detailing the change in ingredient(s) on their website, including date and lot information, to allow food allergic consumers to confirm if a product is still “safe.” CSPI signed this letter along with the following groups:
- Asthma and Allergy Foundation of America
- Allergy Advocacy Association
- Allergy & Asthma Network
- AllergyStrong
- American Partnership for Eosinophilic Disorders (APFED)
- Center for Science in the Public Interest
- CURED Nfp
- E.A.T (End Allergies Together, Inc.)
- Elijah-Alavi Foundation